Cargando…

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy

Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an effective therapeutic strategy in patients with symptomatic heart failure with a reduced left ventricular ejection fraction (LVEF) of 35% or less and a QRS duration of 130 ms or more. The etiology of heart failur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoshiki, Hisashi, Mitsuyama, Hirofumi, Watanabe, Masaya, Mitsuhashi, Takeshi, Shimizu, Akihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634673/ https://www.ncbi.nlm.nih.gov/pubmed/29021842 http://dx.doi.org/10.1016/j.joa.2017.03.002

Ejemplares similares

Cardiac resynchronization therapy with a defibrillator in non‐ischemic and ischemic patients for primary and secondary prevention of sudden cardiac death: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Trends in the use of implantable cardioverter‐defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2020)

Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2016)

Prognostic significance of nonsustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2018)

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy
por: Wang, Qi, et al.
Publicado: (2017)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy
por: Yu, Ziqing, et al.
Publicado: (2017)

Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy
por: Rosman, Jonathan, et al.
Publicado: (2007)

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
por: Obrzut, Sebastian, et al.
Publicado: (2010)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
por: Beiert, Thomas, et al.
Publicado: (2018)

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
por: Imamura, Teruhiko
Publicado: (2020)

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score
por: Yang, Shengwen, et al.
Publicado: (2020)

Current status and role of programmed ventricular stimulation in patients without sustained ventricular arrhythmias and reduced ejection fraction: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2020)

LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary Study
por: Tsai, Shih-Chuan, et al.
Publicado: (2016)

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study
por: Yang, P S, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Dilemma with the route of venous access for hemodialysis catheter insertion in a patient with dilated ischemic cardiomyopathy treated by cardiac resynchronization therapy
por: Ashokananda, Devanahalli, et al.
Publicado: (2016)

Long‐term reliability of the defibrillator lead inserted by the extrathoracic subclavian puncture
por: Watanabe, Masaya, et al.
Publicado: (2018)

Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
por: Mizukami, Kazuya, et al.
Publicado: (2017)

Is routine cardiac MRI justifiable in patients with non-ischemic cardiomyopathy?
por: Kozeski, Gorgi, et al.
Publicado: (2009)

Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy
por: Bhaskaran, Ashwin, et al.
Publicado: (2019)

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial
por: Ghotbi, Adam Ali, et al.
Publicado: (2015)

Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure—Role of the Goldenberg risk score
por: Merkel, Eperke D., et al.
Publicado: (2023)

Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review
por: Shehram, Muhammad, et al.
Publicado: (2023)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Wang, Norman C., et al.
Publicado: (2021)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Reparative resynchronization in ischemic heart failure: an emerging strategy
por: Yamada, Satsuki, et al.
Publicado: (2014)

Social Inequalities in Non-ischemic Cardiomyopathies
por: Amiya, Eisuke
Publicado: (2022)

Accurate Classification of Non-ischemic Cardiomyopathy
por: Wang, Yifan, et al.
Publicado: (2023)

The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
por: Wang, Xianyun, et al.
Publicado: (2015)

Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2016)

Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy
por: Zhang, Zhi-hua, et al.
Publicado: (2020)

Computational Modeling for Cardiac Resynchronization Therapy
por: Lee, Angela W C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vl1pf2u3nnnuilqdcotdt6r99j